Omada Health, Inc. (NASDAQ:OMDA)
| Market Cap | $736.39M-36.2% |
| Revenue (ttm) | $333.04M+43.3% |
| Net Income | $14.03M+153.6% |
| EPS | $0.22+146.6% |
| Shares Out | 62.04M |
| PE Ratio | 49.89 |
| Forward PE | 19.60 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,711,568 |
| Open | $12.23 |
| Previous Close | $12.50 |
| Day's Range | $11.76 - $12.64 |
| 52-Week Range | $10.28 - $25.45 |
| Beta | 2.12 |
| Analysts | Buy |
| Price Target | $28.17(+137.32%) |
| Earnings Date | Mar 4, 2027 |
About OMDA
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
5 firms rating OMDA in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 4, 2027Earnings report
$OMDA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in OMDA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OMDA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OMDA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OMDA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OMDA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OMDA
| VTIVanguard Morningstar Total Stock Market ETF | $27.91M |
| IWMiShares Russell 2000 ETF | $15.70M |
| VXFVanguard Extended Market ETF | $11.36M |
| IWOiShares Russell 2000 Growth ETF | $5.62M |
| VTWOVanguard Russell 2000 ETF | $5.26M |
| FYCFirst Trust Small Cap Growth AlphaDEX Fund | $4.27M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from OMDA’s recent data — informational, not investment advice
What’s Behind the Score
News check: Omada demonstrating AI innovation and GLP-1 program results; raised guidance and market positioning noted, though CEO transition creates some uncertainty.
Recent Insider Activity
Insider Score Trend Over Time
-37.0 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| XHS | State Street SPDR S&P Health Care Services ETF | 1.11% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.41% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.36% |
| MILN | Global X - Millennial Consumer ETF | 0.36% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 0.25% |
| ISMD | Inspire Small/Mid Cap ETF | 0.14% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.13% |
| IHF | iShares U.S. Healthcare Providers ETF | 0.10% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.07% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.07% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.06% |
| IWO | iShares Russell 2000 Growth ETF | 0.05% |
Weight is the stock’s share of each fund’s holdings.
